Inventor

Catherine M. Rohloff

Inventor
Los Altos, CA, US

Overview

24→
Patents
2010–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
Y10TTechnical subjects covered by former us classification17%
A61MDevices for introducing media into, or onto, the body6%
C07KPeptides6%
A61FFilters implantable into blood vessels2%
PatentTitleYear
10,441,528Devices, formulations, and methods for delivery of multiple beneficial agents201910,363,287Method of manufacturing an osmotic delivery device20199,724,293'Methods of manufacturing viscous liquid pharmaceutical formulations'20179,682,127'Osmotic delivery device comprising an insulinotropic peptide and uses thereof'20179,572,889'Devices, formulations, and methods for delivery of multiple beneficial agents'20179,526,763'Solvent/polymer solutions as suspension vehicles'20169,095,553'Solvent/polymer solutions as suspension vehicles'20158,940,316'Osmotic delivery comprising an insulinotropic peptide and uses thereof'20158,926,595'Devices, formulations, and methods for delivery of multiple beneficial agents'20158,496,943'Non-aqueous single phase vehicles and formulations utilizing such vehicles'20138,460,694'Solvent/polymer solutions as suspension vehicles'20138,440,226'Solvent/polymer solutions as suspension vehicles'20138,398,967'Particle formulations for use in pharmaceutical compositions'20138,343,140'Devices, formulations, and methods for delivery of multiple beneficial agents'20138,299,025'Suspension formulations of insulinotropic peptides and uses thereof'20128,257,691'Composition and dosage form comprising a particle formulation and suspending vehicle'20128,211,467'Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles'20128,206,745'Solvent/polymer solutions as suspension vehicles'20128,114,437'Solvent/polymer solutions as suspension vehicles'20128,114,430'Polyoxaester suspending vehicles for use with implantable delivery systems'20127,964,183'Composition and dosage form comprising a particle formulation and suspending vehicle'20117,959,938'Polyoxaester suspending vehicles for use with implantable delivery systems'20117,731,947'Composition and dosage form comprising an interferon particle formulation and suspending vehicle'20107,655,254'Implantable device for continuous delivery of interferon'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2019Patents assigned to INTARCIA THERAPEUTICS INC (23)· patent assignee history
2010–2019Based in Los Altos, CA, US· patent location history
2011–2012Based in Cupertino, CA, US· patent location history
2012–2015Patents assigned to ROHLOFF CATHERINE M (10)· patent assignee history
2012–2013Patents assigned to DESJARDIN MICHAEL A (6)· patent assignee history
2012–2013Patents assigned to AYER RUPAL A (5)· patent assignee history
2012–2013Patents assigned to CHEN GUOHUA (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTARCIA THERAPEUTICS INC232010–2019
ROHLOFF CATHERINE Mself102012–2015
DESJARDIN MICHAEL A62012–2013
AYER RUPAL A52012–2013
CHEN GUOHUA52012–2013
Locations
LocationPatentsSpan
Los Altos, California, US222010–2019
Cupertino, California, US22011–2012